Screening for Social Weaknesses and Coordination Course of Cancer Patients
DEFCOCANCERO
1 other identifier
interventional
71
1 country
1
Brief Summary
The main objective of the study is to validate a methodology with Psychometric tool to measure levels of patients social fragility. This tool will be dematerialized on a tablet. The answers will be then processed by a decision support algorithm, which automatically send an alert to detection of social fragility of the patient to the nurse navigators.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable cancer
Started Jul 2014
Shorter than P25 for not_applicable cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2015
CompletedFirst Submitted
Initial submission to the registry
February 6, 2015
CompletedFirst Posted
Study publicly available on registry
February 24, 2015
CompletedFebruary 26, 2016
February 1, 2016
7 months
February 6, 2015
February 25, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Questionnaire validity
Outcomes are content validity by expert judges method, appearance validity through a consensus, construct validity through exploratory factor analysis, discriminant validity in relation to the social fragility through univariate analysis, internal validity through factor analysis
1 hour
Study Arms (1)
Questionnaire and interview
EXPERIMENTALThe patient complete the questionnaire on the tablet to better know their social situation and any difficulties. Then, he will be interview during thirty minutes with a social worker and a nurse navigator. At the end of this intervention we will be offered to the patient monitoring and appropriate resources to its situation.
Interventions
Eligibility Criteria
You may qualify if:
- All new patients enter ICLN for a diagnosis of cancer
- Patients who can read French or patients who can not read French, but accepting the translation by a close friend or family
- Patient having signed a free and informed consent
You may not qualify if:
- Refusal of participation, major patients protected under guardianship.
- Patient can not read French without possibility of translation by a close friend or family
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Institut de Cancerologie de la Loire
Saint-Priest-en-Jarez, 42271, France
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Franck Chauvin, PhD-MD
INSTITUT DE CANCEROLOGIE DE LA LOIRE
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 6, 2015
First Posted
February 24, 2015
Study Start
July 1, 2014
Primary Completion
February 1, 2015
Study Completion
February 1, 2015
Last Updated
February 26, 2016
Record last verified: 2016-02